A safer workplace for healthcare professionals.

 

 

DESCRIPTION

Systems to make the handling of chemotherapeutic and other toxic pharmaceuticals safe in order to protect the population exposed to these hazards on a daily basis: healthcare providers.

 

This containment system is a closed-system transfer device that enables caretakers to handle drugs safely during and after administration.

 

PROBLEM ADDRESSED

CDC recent a ten-year study found that chemotherapy drugs used to treat cancer have been contaminating the workplaces where they are used. Despite rigorous current safety precautions, these drugs were found in the urine of healthcare professionals who handled the drugs,

 

Healthcare professionals caring for chemotherapy patients are at risk of chronic exposure to toxins.

 

MARKET

An estimated 5.5 million US healthcare workers are exposed every year to hazardous drugs due to poor containment.

 

This usually results in cancer, genetic mutations, infertility, birth defects and miscarriages according to OSHA, NIOSH, and the Joint Commission.

 

The technology that has an opportunity to prevent cancer and/or infertility for those with routine exposure to harsh chemicals in drugs they handle daily.

 

Design flaws in current solutions have left medical centers searching for more effective options to protect caregivers.

 

TECHNOLOGY

A disposable containment device that enables safer and more efficient handling of hazardous drugs economically.

 

This technology meets the primary concern of liquid spills and vapor leaks. It has more efficient dosage preparation and is fully compliant which allows for widespread immediate implementation.

 

The company has identified and adopted a methodology that is far more efficient than any other alternatives on the market with its proprietary technology.

 

Six (6) patents allowed with broad claims coverage have been issued and sixteen (16) patents with clear freedom-to-operate analysis updated quarterly are pending.

 

OPPORTUNITY

There is a $1 B worldwide market opportunity. The $500 MM U.S. market is growing at 25% per year, driven by increasing cancer treatments and safety demands from workers, safety organizations, and government regulations. 

 

 

CLICK HERE FOR THE CEO INTERVIEW